Data Sheet 1_Methylglyoxal hampers the angiogenic capacity of human retinal endothelial cells modifying cell transcriptome with the contribution of NRSF/REST.pdf

Transcriptomic profiles were compared with independent human DR datasets, and REST was silenced by siRNAs followed by analyses of proangiogenic function.</p>Results<p>The exposure of hRECs to MGO for 72 h is sufficient to increase protein glycation adducts, impair the migration, tube-formation and the recruitment of pericytes. Transcriptome and miRNome analyses highlight that MGO induces extensive transcriptional perturbations, related to gene expression regulation, cell cycle, cell death and vasculature development.

Among the identified transcriptional regulators, Neuron-Restrictive Silencer Factor/RE1-Silencing Transcription Factor (NRSF/REST) emerges as a candidate mediator, with binding sites enriched in 56% of deregulated genes. NRSF/REST expression markedly increases after 24 h of MGO treatment, suggesting it is an early event of the exposure to MGO. Protein–protein interaction network analysis prioritized NRSF/REST as a central node linking key MGO-responsive pathways.

Accordingly, NRSF/REST knockdown is associated with the reduction of TP53 and FOSL2, which are induced by MGO and display NRSF binding sites and known migration-related functions. Importantly, REST silencing significantly attenuates MGO-induced defects in endothelial migration, tube formation and pericyte recruitment, supporting its contribution to both transcriptional and functional endothelial alterations induced by MGO in hRECs.</p>Conclusion<p>These findings demonstrate that MGO exposure disrupts endothelial function and transcriptional homeostasis in hRECs, identifying NRSF/REST as a contributor to MGO-induced endothelial dysfunction and supporting further investigations of the MGO/NRSF-REST axis as a potential therapeutic target for DR.</p>